| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 1,459 | 1,606 | 1,182 | | Cost of Revenue | 485 | 653 | 181 | | | Gross Profit | 974 | 954 | 1,001 | | | Operating Expenses | | Research Development | 2,357 | 2,115 | 1,610 | | Selling General and Administrative | 6,300 | 6,641 | 5,458 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
| 20 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (7,683) | (7,802) | (6,087) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 95 | 299 | (26) | | Earnings Before Interest And Taxes | (7,588) | (7,503) | (6,113) | | Interest Expense |
-
|
-
| 1,666 | | Income Before Tax | (7,588) | (7,503) | (7,779) | | Income Tax Expense | (254) |
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,334) | (7,503) | (7,779) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (7,334) | (7,503) | (7,779) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,334) | ($7,503) | ($7,779) |
|
0.83% Nasdaq 
Income Statement
